Australia - English - APVMA (Australian Pesticides and Veterinary Medicines Authority)

boehringer ingelheim animal health australia pty. ltd. - cysteine - l hydrochloride monohydrate; phenylalanine-l; histidine-l hydrochloride monohydrate; isoleucine - l; lysine-l monohydrochloride; leucine-l; methionine - l; glutamine-l; arginine-l hydrochloride; threonine-l; valine - l; tryptophan-l; glucose monohydrate; edta disodium salt; calcium chloride dihydrate; potassium chloride; magnesium sulfate; sodium acetate; vitamin b2 as riboflavin 5-phosphate sodium; vitamin b12 = cyanocobalamin; vitamin b3 = nicotinamide; vitamin b1 hydrochloride = thiamine hydro - parenteral liquid/solution/suspension - cysteine - l hydrochloride monohydrate amino acid-cysteine-l active 34.0 mg/100ml; phenylalanine-l amino acid-phenylalanine-l active 102.0 mg/100ml; histidine-l hydrochloride monohydrate amino acid-histidine active 34.0 mg/100ml; isoleucine - l amino acid-isoleucine-l active 68.0 mg/100ml; lysine-l monohydrochloride amino acid-lysine-l active 102.0 mg/100ml; leucine-l amino acid-leucine active 136.0 mg/100ml; methionine - l amino acid-methionine-l active 34.0 mg/100ml; glutamine-l amino acid-glutamine-l active 136.0 mg/100ml; arginine-l hydrochloride amino acid-arginine-l active 85.0 mg/100ml; threonine-l amino acid-threonine-l active 68.0 mg/100ml; valine - l amino acid-valine active 170.0 mg/100ml; tryptophan-l amino acid-tryptophan-l active 34.0 mg/100ml; glucose monohydrate carbohydrate active 5.0 g/100ml; edta disodium salt chelating agent-mineral active 15.0 mg/100ml; calcium chloride dihydrate mineral-calcium-salt active 15.0 mg/100ml; potassium chloride mineral-potassium active 20.0 mg/100ml; magnesiu - nutrition & metabolism - cattle | horse | pigs | sheep | beef | boar | bos indicus | bos taurus | bovine | buffalo | bull | bullock | calf | colt | cow | - animal - debilitated condition | diarrhoea | vomiting | absorptive | acute diarrhoea | acute intestinal catarrh | avian blackhead | bacterial enteritis | blackhead | chronic diarrhoea | coccidiosis | dietary factors | dietary upset | enteritis | feed conversion | flatulance | fluid loss | gastro-intestinal | gram negative bacteria | growth rate | k88+ serotypes of e.coli | nesting diarrhoea | non-specific irritants | poisoning | postweaning scours | prophylactic | scours | streptomycin sensitive bacteri | sulphadiazine sensitive bacter | sulphonamide sensitive bacteri | trichomoniasis | trimethoprim sensitive bacteri | white scours

Australia - English - APVMA (Australian Pesticides and Veterinary Medicines Authority)

boehringer ingelheim animal health australia pty. ltd. - histidine-l hydrochloride monohydrate - unknown - histidine-l hydrochloride monohydrate amino acid-histidine active 0.0 - active constituent

United States - English - NLM (National Library of Medicine)

b. braun medical inc. - histidine (unii: 4qd397987e) (histidine - unii:4qd397987e), isoleucine (unii: 04y7590d77) (isoleucine - unii:04y7590d77), leucine (unii: gmw67qnf9c) (leucine - unii:gmw67qnf9c), lysine acetate (unii: ttl6g7liwz) (lysine - unii:k3z4f929h6), methionine (unii: ae28f7pnpl) (methionine - unii:ae28f7pnpl), phenylalanine (unii: 47e5o17y3r) (phenylalanine - unii:47e5o17y3r), threonine (unii: 2zd004190s) (threonine - unii:2zd004190s), tryptophan (unii: 8duh1n11bx) (tryptophan - unii:8duh1n11bx), valine (unii - histidine 0.25 g in 100 ml - 5.4% nephramine® (essential amino acid injection) is indicated for adult and pediatric use, in conjunction with other measures, to provide nutritional support for uremic patients, particularly when oral nutrition is infeasible or impractical. see warnings, precautions, pediatric use , special precautions in pediatric patients , and dosage and administration . nephramine® is contraindicated in patients with severe, uncorrected electrolyte and acid-base imbalance, hyperammonemia, decreased (subcritical) circulating blood volume, inborn errors of amino acid metabolism, or hypersensitivity to one or more amino acids present in the solution.

United States - English - NLM (National Library of Medicine)

professional complementary health formulas - l-histidine 4x, 7x, 12x - for the temporary relief of minor joint pain or stiffness, indigestion, or symptoms of seasonal or food allergies.* *claims based on traditional homeopathic practice, not accepted medical evidence. not fda evaluated.

United States - English - NLM (National Library of Medicine)

professional complementary health formulas - l-histidine 15x, 20x, 30x, 60x, 200x - for the temporary relief of minor joint pain or stiffness, indigestion, or symptoms of seasonal or food allergies.* *claims based on traditional homeopathic practice, not accepted medical evidence. not fda evaluated.

Australia - English - Department of Health (Therapeutic Goods Administration)

bio concepts pty ltd - histidine, quantity: 800 mg/g - powder, oral - excipient ingredients: glycine; colloidal anhydrous silica; siraitia grosvenorii - maintain/support (state vitamin/mineral/nutrient) levels in the body ; maintain/support (state vitamin/mineral) within normal range

Australia - English - Department of Health (Therapeutic Goods Administration)

novo nordisk pharmaceuticals pty ltd - histidine, quantity: 12.57 mg - injection, solution - excipient ingredients: hydrochloric acid; water for injections; sodium hydroxide - novoseven rt is indicated for the control of bleeding and surgical prophylaxis in patients: with inhibitors to coagulation factors viii or ix; with congenital fvii deficiency; with glanzmann's thrombasthenia, who have antibodies to gpiib-iiia and/or hla, and with past or present refractoriness to platelet transfusions.

Australia - English - Department of Health (Therapeutic Goods Administration)

novo nordisk pharmaceuticals pty ltd - histidine, quantity: 8.01 mg - injection - excipient ingredients: water for injections; hydrochloric acid; sodium hydroxide - novoseven rt is indicated for the control of bleeding and surgical prophylaxis in patients: with inhibitors to coagulation factors viii or ix; with congenital fvii deficiency; with glanzmann's thrombasthenia, who have antibodies to gpiib-iiia and/or hla, and with past or present refractoriness to platelet transfusions.

Australia - English - Department of Health (Therapeutic Goods Administration)

novo nordisk pharmaceuticals pty ltd - histidine, quantity: 3.26 mg - injection - excipient ingredients: hydrochloric acid; sodium hydroxide; water for injections - novoseven rt is indicated for the control of bleeding and surgical prophylaxis in patients: with inhibitors to coagulation factors viii or ix; with congenital fvii deficiency; with glanzmann's thrombasthenia, who have antibodies to gpiib-iiia and/or hla, and with past or present refractoriness to platelet transfusions.

Australia - English - Department of Health (Therapeutic Goods Administration)

novo nordisk pharmaceuticals pty ltd - histidine, quantity: 1.74 mg - injection - excipient ingredients: water for injections; sodium hydroxide; hydrochloric acid - novoseven rt is indicated for the control of bleeding and surgical prophylaxis in patients with: inhibitors to coagulation factors viii or ix; with congenital fvii deficiency; with glanzmann's thrombasthenia, who have antibodies to gpiib-iiia and/or hla, and with past or present refractoriness to platelet transfusions.